3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
3
Terminated
1
Recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gastrointestinal
5
Sarcoma
2
Gynecologic
2
CNS
2
Thoracic
1
Other neoplasm
1
NET
1
Myeloid
1
Head & Neck
1
Genitourinary
1
Endocrine
1
Dermatologic
1
Breast
1
Conditions
Neuroendocrine Tumors
110
Pheochromocytoma
33
Carcinoma, Neuroendocrine
32
Pituitary Neoplasms
28
Thyroid Cancer, Papillary
26
Paraganglioma
26
Adrenocortical Carcinoma
21
Neoplasms
19
Gastro-enteropancreatic neuroendocrine tumor
19
Thyroid Neoplasms
17
Adrenal Gland Neoplasms
16
Multiple Endocrine Neoplasia Type 1
14
Stomach Neoplasms
13
Pancreatic Neoplasms
13
Carcinoid Tumor
13
Prostatic Neoplasms
12
Lung Neoplasms
12
Thyroid Carcinoma, Anaplastic
11
Sarcoma
11
Breast Neoplasms
11
Adenoma, Islet Cell
11
Small Cell Lung Carcinoma
10
Neuroblastoma
10
Neoplasm Metastasis
10
Colorectal Neoplasms
10
Carcinoma, Hepatocellular
10
Brain Neoplasms
10
Ovarian Neoplasms
9
Meningioma
9
Esophageal Neoplasms
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Neoplasms, Glandular and Epithelial
×
Endocrine
×
Clear all
NCT07377487
2026-05-22
INDIGO
Boston Scientific Corporation
Phase NA
Recruiting
51 enrolled